Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
90.34
-0.65 (-0.71%)
Nov 13, 2024, 4:00 PM EST - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $6.42 billion as of November 13, 2024. Its market cap has increased by 97.54% in one year.
Market Cap
6.42B
Enterprise Value
5.25B
1-Year Change
97.54%
Ranking
Category
Stock Price
$90.34
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $6.42B, an increase of 706.43%. That is a compound annual growth rate of 88.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2024 | 6.42B | 39.27% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 7.42B |
| Legend Biotech | 7.41B |
| Bausch + Lomb | 7.20B |
| Elanco Animal Health | 6.98B |
| Cytokinetics | 6.95B |
| RadNet | 6.59B |
| Blueprint Medicines | 6.47B |
| Ionis Pharmaceuticals | 6.25B |